Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Share News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Supermarket REIT Ups Stake In Sainsbury's Portfolio

Thu, 18th Feb 2021 12:15

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Supermarket Income REIT PLC - real estate investment trust dedicated to investing in supermarket property - Doubles stake in UK's portfolios of Sainsbury's supermarket properties from an Aviva Investors managed fund. Stake in the portfolio upped to 51% from 25.5%. The 25.5% interest has been acquired through the company's existing 50-50 joint venture with British Airways Pension Trustees Ltd. The purchase price is GBP115.0 million, meaning the company's contribution to the JV to fund the acquisition is GBP57.5 million. The JV acquired its initial 25.5% interest from British Land PLC in May last year. Following this second acquisition, the JV's ownership in the portfolio is 51%. The remaining 49% beneficial interest is held by J Sainsbury PLC. The portfolio was originally created through two sale and leaseback transactions by Sainsbury's in 2000 and consists of the freehold interest in 26 Sainsbury's supermarkets. Company reiterates strategic rationale remains "compelling for this high quality portfolio of predominantly omnichannel supermarkets".

----------

Brunner Investment Trust PLC - active investment globally - Net asset value per share ends November at 988.7 pence, up from 945.8p at same point year before. Total net assets improve to GBP422.1 million from GBP403.8 million. Proposes final dividend of 6.05p, brining total dividend to 20.06p - up from 19.98p year before. NAV total return 6.2%, which is ahead of the composite benchmark index, 70% FTSE World Ex-UK and 30% FTSE All-Share Index, which rose by 5.3%. Company says: "There are some key themes that we see driving the portfolio, such as digitalisation, stretching beyond just the tech companies, global demographics and the energy transition. That said, despite these strong themes proving to be drivers of growth, the manager's overriding strategy remains to find individual companies from a bottom up perspective that provide the requisite quality and growth characteristics, at sensible valuations."

----------

Trifast PLC - Uckfield, England-based industrial fastenings firm - Says trading levels continue to strengthen, with group revenues up about 5% year-on-year in the four-month period to the end of January 2021 at constant currency. "As always, March represents a key trading month for the group, however at present run rates, we expect financial 2021 revenues to exit slightly ahead of current market expectations," company says. Will reinstate dividends, to recommend final dividend for financial 2021, ending March 2022. Company adds: "The group's continued recovery, in addition to a strong pipeline and high activity levels, provides a solid base for the business to move forward. As a full-service provider to our multinational customers, delivering reliable product engineering, quality and supply, via flexible global logistics solutions, we believe it is these core skills that will allow us to maintain growth by increasing market share across a wide customer base."

----------

Arbuthnot Banking Group PLC - London-based private and commercial banking - Expects 2020 pre-tax loss better than current market expectations. Reported GBP7.0 million profit in 2019. Sees increase in loan enquiries in lending markets in fourth quarter, as business activity continued to increase. "The return to pre-pandemic credit appetites enabled the business to develop new lending pipelines that we expect to draw in 2021," lender says. Plans 21p special dividend, in line with dividend declared, but then suspended, prior to pandemic. Company adds: "Given that the full year results of the group in 2020 will record a loss before tax, the board has decided that no dividend will be paid in respect of 2020. The directors will monitor the trading performance of the group for 2021, and taking note of the guidance from the PRA will decide on the appropriate distribution policy for further dividends in 2021, as the group's results improve after suffering the effects of the pandemic and the reduction in base rates during 2020."

----------

essensys PLC - London-based software for flexible workspace operators - Sees robust performance in the first half of the year, ended January 31, with revenue in line with management expectations at GBP10.6 million. "Despite the continued impact of Covid-19 the Group's US business continues to grow strongly with half year recurring revenue increasing 18% to GBP4.4 million from GBP3.8 million whilst the UK business continues to prove its resilience," company says. Connect site churn remains very low at 3% year to date. Company closes the half year with 431 live Connect sites, a net increase of 8% year-on-year. Annual recurring revenue run rate at GBP19.9 million was slightly ahead of year before at GBP19.7 million. Notwithstanding continued uncertainty around the short-term impact of Covid-19, the company continues to expect current year financial performance to be in line with market estimates.

----------

MGC Pharmaceuticals Ltd - medicinal cannabis firm - Signs minimum 3-year exclusive master supply and distribution agreement with European nutraceutical producer and distributor, Swiss PharmaCan AG for the sale and distribution of the company's food supplement ArtemiC product line. ArtemiC is a clinically tested food supplement containing four natural based ingredients consisting of artemisinin, curcumin, boswellia serrata, and vitamin C. "The agreement represents the first sales of ArtemiC as a food grade product and provides MGC Pharma direct access to the large and rapidly growing markets that are still reporting high numbers of Covid-19 cases," company says. It adds, the agreement includes a minimum wholesale order quantity of 40,000 units of per quarter and an initial wholesale order of 10,000 has already been received from SPC. This initial 10,000 unit order equates to a retail market value of USD850,000 to SPC.

----------

JKX Oil & Gas PLC - UK-based hydrocarbon exploration and production company - Says Hungarian regulators kibosh sale of company's wholly owned Hungarian subsidiary, Folyopart Energia KFT. JKX had agreed sale in March last year to Starhol Holding Ltd for USD2.90 million in cash. Folyoport, JKX said, is also known as Riverside Energy KFT. But now Hungarian authorities have refused the necessary consent to the transaction pursuant to legislation introduced as a result of the current Covid-19 pandemic. Consequently, the transaction will not proceed. JKX CEO Victor Gladun says: "Despite this development JKX will continue to explore other options in relation to Riverside in line with our previously announced strategy of focusing our portfolio on our most prospective opportunities."

----------

Inspiration Healthcare Group PLC - Crawley, West Sussex-based medical devices - Expects annual revenue, for year ended January 31, to exceed GBP36.8 million, representing an increase of 52% from the year before with the inclusion of SLE, Viomedex and the one time ventilator orders relating to Covid-19 in the UK. As previously noted, Ebitda is expected to be not less than GBP4.9 million, representing growth of more than 53% year on year. Chief Executive Neil Campbell says: "I am delighted to confirm that the group achieved a record turnover in the last financial year against a backdrop of uncertainty caused by the Covid-19 pandemic and Brexit. It demonstrates that the group is well balanced in terms of products and services. We are pleased with the progress of integration of the SLE business into the group along with its contribution to growth and we are well positioned to continue growth this year and beyond."

----------

Altus Strategies PLC - Africa-focused mining royalty company - Reverse circulation drilling has extended the strike length of the TS prospect by at least 150 metres, to beyond 3 kilometres at the Tabakorole gold project in southern Mali. Altus notes intersections include 2.0 grammes per tonne over 23 metres from 178 metres, 1.24 grammes per tonne over 24 metres from 13 metres, and 0.81 grammes per tonne over 25 metres from surface. Altus holds a 49% equity interest and 2.5% net smelter return royalty on the project. Exploration activities at Tabakorole are being funded by Marvel Gold Ltd under its joint venture with Altus.

----------

Canadian Overseas Petroleum Ltd - oil and gas company focused on Sub-Saharan Africa - Says previously announced USD65 million senior credit facility approved by lender, a US based investment firm. Says approval significant positive step in the previously disclosed planned process of obtaining financing and completing the closing of its acquisition of Atomic Oil & Gas LLC. Facility has term of four years and has base size of USD45 million, with an additional, or "accordion", USD20 million to fund future development at the sole discretion of the lender. "The terms of the facility are market competitive and availability of the facility remains subject to execution of final definitive loan documentation and satisfaction of customary conditions precedent," company adds.

----------

TomCo Energy PLC - unconventional hydrocarbon development in US - Pretax loss in year to September 30, widens to GBP1.1 million from GBP782,000 year before. Did not generate revenue in either period. Administrative expenses rise to GBP1.0 million from GBP778,000. Postponed next stage of the TurboShale field testing at start of 2020. "A decision on when to restart the field test programme is likely to be made in the second quarter of 2021," TomCo says. Company adds: "The directors note that Covid-19 has had a significant negative impact on the global economy and oil prices have been volatile, which may mean it is harder to secure additional funding than it has historically been. Notwithstanding this, the Directors have a reasonable expectation based on successful recent fundraisings, that they can secure any additional funding that might be required."

----------

Mycelx Technologies Corp - clean water firm based in Minnesota - Sells building in Duluth, Georgia. Sale will allow company to right-size its office space needs across its three operating locations. Will net a cash consideration of USD5.4 million. Has a debt obligation of about USD2.6 million on the property, so the net cash proceeds are expected to be in the range of USD2.8 million. The current net book value of the property is USD2.9 million, so MYcelx will recognise a financial gain of about USD2.5 million. Notes, when the building was originally purchased, the company's engineering and business development capability was based in Duluth. However, now has other offices across the globe and subsequently, personnel have relocated to these locations resulting in vacant office space.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Jul 2023 08:25

IN BRIEF: MGC Pharmaceuticals raises GBP650,000 in subscription

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in the production and development of plant-derived medicines - Conditionally raises GBP650,000, before expenses, through a placing and subscription of 541.7 million shares at a price of 0.12 pence per share. This represents a 57% discount from the closing price of 0.28p per share on Wednesday. The company also raises GBP50,000 from its Chief Executive Officer & Managing Director Roby Zomer in a convertible loan agreement.

Read more
12 Jul 2023 11:12

IN BRIEF: MGC Pharma to receive USD150,000 downpayment for AMC order

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in the production and development of plant-derived medicines - Clarifies that it will receive USD150,000 down payment on a USD1 million order for ArtemiC placed by AMC last week. Says further USD850,000 will be paid upon completion of production and dispatch of the order, expected for September.

Read more
7 Jul 2023 09:41

MGC Pharmaceuticals shares up after USD1 million ArtemiC order

(Alliance News) - MGC Pharmaceuticals Ltd shares jumped on Friday morning after it announced a USD1 million order from AMC Pharma to produce ArtemiC, an over-the-counter version of CimetrA.

Read more
3 Jul 2023 17:31

TRADING UPDATES: Mycelx wins deal; 88 Energy buys in Texas

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Jun 2023 14:07

TRADING UPDATES: Pendragon quarterly trading momentum maintained

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Jun 2023 15:44

UK shareholder meetings calendar - next 7 days

Friday 23 June 
Cadogan Petroleum PLCAGM
Mears Group PLCAGM
Non-Standard Finance PLCAGM
Ocean Harvest Technology Group PLCAGM
Oxford Biomedica PLCAGM
Pelatro PLCAGM
Petrofac LtdAGM
Princess Private Equity Holding LtdAGM
Rathbones Group PLCGM re agreement regarding all-share combination with Invested Wealth & Investment Ltd
Supply@Me Capital PLCGM re open offer warrantholders
Vietnam Enterprise Investments LtdAGM
VPC Specialty Lending Investments PLCAGM
Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
Thursday 29 June 
3i Group PLCAGM
Africa Opportunity Fund LtdAGM
Anemoi International LtdAGM
Anpario PLCAGM
Ariana Resources PLCAGM
Beowulf Mining PLCAGM
Celadon Pharmaceuticals PLCAGM
Cornish Metals IncAGM
East Imperial PLCAGM
East Star Resources PLCAGM
Eden Research PLCAGM
Engage XR Holdings PLCAGM
First Class Metals PLCAGM
Gresham House Energy Storage Fund PLCGM re remuneration policy
Gusbourne PLCAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Ingenta PLCAGM
IQE PLCAGM
Kooth PLCAGM
Landore Resources LtdAGM
Let's Explore Group PLCAGM
Likewise Group PLCAGM
MGC Pharmaceuticals LtdGM re issue of convertible notes
Morgan Advanced Materials PLCAGM
NetScientific PLCAGM
New Century AIM VCT 2AGM
Norman Broadbent PLCAGM
Reabold Resources PLCAGM
Rockhopper Exploration PLCAGM
Roquefort Therapeutics PLCAGM
Serica Energy PLCAGM
SpaceandPeople PLCAGM
Symphony Environmental Technologies PLCAGM
Synairgen PLCAGM
Thalassa Holdings LtdAGM
tinyBuild IncAGM
Touchstone Exploration IncAGM
Trident Royalties PLCAGM
Unigel Group PLCAGM
Verici Dx PLCAGM
Xpediator PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
31 May 2023 12:09

IN BRIEF: MGC Pharmaceuticals epilepsy treatment delivered in UK

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Says its investigational medicinal product, CannEpil, has been successfully delivered to its first UK patients through I Am Billy Foundation. Says CannEpil also has been delivered to its first patient in the UK through a named patient request programme.

Read more
30 May 2023 18:27

IN BRIEF: MGC Pharmaceuticals rejigs board to reflect strategic change

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Says Brett Mitchell and Nativ Segev, will step down from the board, reflecting the changing direction of the company as it moves away from the medicinal cannabis sector toward a more pharma-focused business strategy. Stephen Parker, currently non-executive director, will replace Mitchell as interim non-executive chair. A new Australian non-executive director will also be appointed. Appoints Oberon Capital as joint broker in the UK with immediate effect alongside Peterhouse Capital.

Read more
13 Apr 2023 17:50

IN BRIEF: MGC Pharmaceuticals completes GBP2.1 million fundraise

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Raises GBP2.1 million via a fundraising announced on Tuesday, which has now closed. Shares issued under the placing will be admitted to London Stock Exchange on April 18. In addition, MGC secures GBP256,590 in a separate offer to Australian and UK high-net-worth investors.

Read more
11 Apr 2023 14:10

IN BRIEF: MGC Pharmaceuticals says CannEpil available in UK

MGC Pharmaceuticals Ltd - Perth, Australia-based pharmaceutical company specialising in plant-inspired medicines - Says its investigational medicinal product CannEpil for patients suffering from refractory epilepsy is now available in the UK by named patient request to be prescribed by doctors. The product is now in the process of a clinical development programme.

Read more
3 Apr 2023 14:32

TRADING UPDATES: Lords Group buys Chiltern Timber; SRT wins contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday not separately reported by Alliance News:

Read more
21 Mar 2023 13:58

MGC Pharma's Covid-19 drug ArtemiC available over-the-counter in US

(Alliance News) - MGC Pharmaceuticals Ltd on Tuesday said its ArtemiC product has now been listed as an over-the-counter, non-prescription drug in the US, while its supply and distribution partner AMC Holdings Inc has placed a USD2 million order.

Read more
15 Mar 2023 15:36

TRADING UPDATES: SigmaRoc Sweden boost; Mosman's Cinnabar-1 success

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
8 Mar 2023 18:24

TRADING UPDATES: Poolbeg patent boost; Resolute Mining resource up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and Tuesday not separately reported by Alliance News:

Read more
28 Feb 2023 14:34

EARNINGS UPDATES: Kitwave hails rise in annual revenue and profit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.